Open tender · Germany · Cn Standard
Open house Arzneimittelrabattverträge Eptinezumab, ATC N02CD05
The work
Non-exclusive discount agreements for the active substance Eptinezumab (ATC N02CD05) with a possible start date of 01.05.2026 and an end date of 30.04.2028.
- Contracts are identical and non-negotiable
- Contract can be terminated with one month's notice at the end of a month
- Agreements are automatically superseded by a national or state-level discount contract for the same substance
Key facts
- Contract period
- from 01.05.2026 to 30.04.2028
- Evaluation
- Not a formal bid evaluation, but a contract offer to all eligible companies
What it takes to qualify
Worth a closer look
- The tender is for an 'open-house' model, not a formal procedure, and is not subject to procurement law.
- The document is in German and relates to a German entity (AOK Bayern).
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- ausgefüllte und unterzeichnete Eigenerklärung zur Zuverlässigkeitmust be signed and submitted
- ausgefüllter und unterzeichneter Vertragmust be signed and submitted
- ausgefüllte und unterzeichnete Anlage "Festlegung der vertragsgegenständlichen Arzneimittel"must be signed and submitted
- Handelsregisterauszugto prove representation authority or a power of attorney
- Vollmachtif representation authority is not clear from the trade register extract